{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:28:36Z","timestamp":1793784516635,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["AA019366"],"award-info":[{"award-number":["AA019366"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["AA07462"],"award-info":[{"award-number":["AA07462"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["AA07611"],"award-info":[{"award-number":["AA07611"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["AA10721"],"award-info":[{"award-number":["AA10721"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["AA20908"],"award-info":[{"award-number":["AA20908"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neuroscience.2022.03.028","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T18:47:29Z","timestamp":1648320449000},"page":"176-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD Procedure"],"prefix":"10.1016","volume":"491","author":[{"given":"Zachary A.","family":"Rodd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Engleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei I.","family":"Molosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheketha R.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neuroscience.2022.03.028_b0005","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev.biophys.29.1.577","article-title":"Unnatural ligands for engineered proteins: new tools for chemical genetics","volume":"29","author":"Bishop","year":"2000","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.03.028_b9000","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0278-5846(98)00035-9","article-title":"Reversible metabolism of clozapine and clozapine Noxide in schizophrenic patients","volume":"22","author":"Chang","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.03.028_b0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002130050344","article-title":"Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs","volume":"132","author":"Carey","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.03.028_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/cn500325v","article-title":"The first structure\u2013activity relationship studies for designer receptors exclusively activated by designer drugs","volume":"6","author":"Chen","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/S0007125000296840","article-title":"General pharmacology of clozapine","volume":"17","author":"Coward","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1073\/pnas.95.1.352","article-title":"Controlling signaling with a specifically designed Gi-coupled receptor","volume":"95","author":"Coward","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.03.028_b0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1074\/jbc.C200588200","article-title":"A Single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a GS-coupled receptor activated exclusively by synthetic ligands (RASSL)","volume":"278","author":"Claeysen","year":"2003","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.neuroscience.2022.03.028_b0045","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00213-018-4970-0","volume":"235","author":"Deehan","year":"2018","journal-title":"Psychopharmacology"},{"issue":"23","key":"10.1016\/j.neuroscience.2022.03.028_b0050","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1007\/s00213-015-4056-1","article-title":"Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats","volume":"232","author":"Deehan","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0055","doi-asserted-by":"crossref","unstructured":"Ding ZM, Engleman EA, Rodd ZA, McBride WJ. Ethanol increases glutamate neurotransmission in the posterior ventral tegmental area of female wistar rats. Alcohol Clin Exp Res. 2012;36(4):633-40. doi: 10.1111\/j.1530-0277.2011.01665.x. Epub 2011 Oct 21. PMID: 22017390; PMCID: PMC4572739.","DOI":"10.1111\/j.1530-0277.2011.01665.x"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0060","doi-asserted-by":"crossref","unstructured":"Ding ZM, Rodd ZA, Engleman EA, McBride WJ. Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol. Alcohol Clin Exp Res. 2009;33(9):1571-81. doi: 10.1111\/j.1530-0277.2009.00985.x. Epub 2009 May 26. PMID: 19485970; PMCID: PMC2861869.","DOI":"10.1111\/j.1530-0277.2009.00985.x"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0065","doi-asserted-by":"crossref","unstructured":"Ding ZM, Rodd ZA, Engleman EA, Bailey JA, Lahiri DK, McBride WJ. Alcohol drinking and deprivation alter basal extracellular glutamate concentrations and clearance in the mesolimbic system of alcohol-preferring (P) rats. Addict Biol. 2013 Mar;18(2):297-306. doi: 10.1111\/adb.12018. Epub 2012 Dec 14. PMID: 23240885; PMCID: PMC3584204.","DOI":"10.1111\/adb.12018"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.03.028_b0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0024-3205(88)90267-6","article-title":"An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates","volume":"43","author":"Donzanti","year":"1988","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nn.4192","article-title":"Chemogenetic disconnection of monkey orbitofrontal and rhinal cortex reversibly disrupts reward value","volume":"19","author":"Eldridge","year":"2016","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.03.028_b0080","first-page":"795","article-title":"Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcohol-preferring rats: effects on dialysate dopamine levels and ethanol intake","volume":"24","author":"Engleman","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.alcohol.2006.03.001","article-title":"Extracellular dopamine levels are lower in the medial prefrontal cortex of alcohol-preferring rats compared to Wistar rats","volume":"38","author":"Engleman","year":"2006","journal-title":"Alcohol"},{"issue":"6350","key":"10.1016\/j.neuroscience.2022.03.028_b0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aan2475","article-title":"Chemogenetics revealed: DREADD occupancy and activation via converted clozapine","volume":"357","author":"Gomez","year":"2017","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.neuroscience.2022.03.028_b0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/BF00973033","article-title":"Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy","volume":"9","author":"Hamberger","year":"1984","journal-title":"Neurochem Res"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.03.028_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fnbeh.2018.00173","article-title":"Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience","volume":"14","author":"Ilg","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0105","doi-asserted-by":"crossref","unstructured":"Khokhar JY, Henricks AM, Sullivan EDK, Green AI. Unique Effects of Clozapine: A Pharmacological Perspective. Adv Pharmacol. 2018;82:137-162. doi: 10.1016\/bs.apha.2017.09.009. Epub 2018. PMID: 29413518; PMCID: PMC7197512.","DOI":"10.1016\/bs.apha.2017.09.009"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2022.03.028_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050692","article-title":"Ethanol and negative feedback regulation of mesolimbic dopamine release in rats","volume":"139","author":"Kohl","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.03.028_b0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2007.05.004","article-title":"Pharmacology of N-desmethylclozapine","volume":"115","author":"Lameh","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0120","doi-asserted-by":"crossref","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, L\u00e4ssig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016\/S0140-6736(13)60733-3. Epub 2013 Jun 27. Erratum in: Lancet. 2013 Sep 14;382(9896):940. PMID: 23810019.","DOI":"10.1016\/S0140-6736(13)60733-3"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.03.028_b0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0731-7085(96)01738-4","article-title":"Characterization of metabolites of clozapine N-oxide in the rat by micro-column high performance liquid chromatography\/mass spectrometry with electrospray interface","volume":"14","author":"Lin","year":"1996","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.03.028_b0130","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0219-16.2016","article-title":"Clozapine N-Oxide Administration Produces Behavioral Effects in Long\u2013Evans Rats: Implications for Designing DREADD Experiments","volume":"3","author":"MacLaren","year":"2016","journal-title":"eneuro"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0135","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1038\/s41598-018-22116-z","volume":"8","author":"Manvich","year":"2018","journal-title":"Weinshenker DSci Rep"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.03.028_b9005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fphys.2019.00521","article-title":"Off-Target Effects of Clozapine-N-Oxide on the Chemosensory Reflex Are Masked by High Stress Levels","volume":"22","author":"Martinez","year":"2019","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.neuroscience.2022.03.028_b0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41593-020-0661-3","article-title":"Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys","volume":"23","author":"Nagai","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2018.03.045","article-title":"Dose-dependent reduction in cocaine-induced locomotion by Clozapine-N-Oxide in rats with a history of cocaine self-administration","volume":"674","author":"Padovan-Hernandez","year":"2018","journal-title":"Neuroscience Letters"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.03.028_b0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/sj.bjp.0703455","article-title":"Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites","volume":"130","author":"Pauwels","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0155","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuroscience.2022.03.028_b0160","series-title":"Polypharmacology in drug discovery","author":"Peters","year":"2012"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.celrep.2019.08.083","article-title":"Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning","volume":"29","author":"Pomrenze","year":"2019","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.03.028_b0170","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/acschemneuro.7b00079","article-title":"Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics","volume":"8","author":"Raper","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.03.028_b0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/pr.117.013995","article-title":"Modulating dopamine signaling and behavior with chemogenetics: concepts, progress, and challenges","volume":"71","author":"Runegaard","year":"2019","journal-title":"Pharmacol Rev"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.03.028_b0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0165-6147(00)01743-0","article-title":"Engineering receptors activated solely by synthetic ligands (RASSLs)","volume":"22","author":"Scearce-Levie","year":"2001","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.03.028_b0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.03.028_b0200","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1476-5381.2011.01638.x","article-title":"Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes","volume":"165","author":"Tanahashi","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.03.028_b0205","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neuropharm.2010.02.017","article-title":"N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M(1) receptor","volume":"58","author":"Thomas","year":"2010","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.03.028_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acsptsci.8b00012","article-title":"DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo","volume":"1","author":"Thompson","year":"2018","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.03.028_b9010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.114.218172","article-title":"Reinforcing properties and neurochemical response of ethanol within the posterior ventral tegmental area are enhanced in adulthood by periadolescent ethanol consumption","volume":"351","author":"Toalston","year":"2014","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:12:45Z","timestamp":1759680765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":42,"alternative-id":["S0306452222001518"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.03.028","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNO Administration Increases Dopamine and Glutamate in the Medial Prefrontal Cortex of Wistar Rats: Further Concerns for the Validity of the CNO-activated DREADD Procedure","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}